Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $9.5800 (-7.53%) ($9.4500 - $10.1700) on Thu. May. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.15% (three month average) | RSI | 58 | Latest Price | $9.5800(-7.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.9% a day on average for past five trading days. | Weekly Trend | ATRA advances 9.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(46%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -4.075% in a week (0% probabilities). VIXM(-31%) VXX(-27%) UNG(-11%) UUP(-9%) TLT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.075% (StdDev 8.15%) | Hourly BBV | 0 () | Intraday Trend | -4.2% | | | |
|
5 Day Moving Average | $10.21(-6.17%) | 10 Day Moving Average | $9.46(1.27%) | 20 Day Moving Average | $8.99(6.56%) | To recent high | -35.1% | To recent low | 68.4% | Market Cap | $712m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |